XML 19 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows - USD ($)
 6 Months Ended
Jul. 03, 2021
Jun. 27, 2020
Cash flows from operating activities:    
Net income $ 103,618,000 $ 120,228,000
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 17,314,000 13,587,000
Stock-based compensation 20,970,000 24,460,000
Loss on disposal of equipment, intangibles and other assets 166,000 196,000
Provision (Benefit) for credit losses 497,000 (170,000)
Benefit from deferred income taxes 0 77,000
Changes in operating assets and liabilities:    
Increase in accounts receivable (38,700,000) (41,295,000)
Decrease (increase) in inventories 8,627,000 (37,548,000)
Decrease (increase) in other current assets 6,456,000 (12,004,000)
Increase in lease receivable, net (7,544,000) (2,183,000)
Increase in deferred costs and other contract assets (1,652,000) (2,105,000)
Increase in other non-current assets (166,000) (442,000)
Increase in accounts payable 1,974,000 32,798,000
Decrease in accrued compensation (16,303,000) (2,025,000)
(Decrease) increase in accrued liabilities (5,998,000) 5,876,000
(Decrease) increase in income tax payable (2,034,000) 248,000
(Decrease) increase in deferred revenue and other contract-related liabilities (1,231,000) 6,920,000
Decrease in other non-current liabilities (736,000) (558,000)
Net cash provided by operating activities 85,258,000 106,060,000
Cash flows from investing activities:    
Maturities of short-term investments 0 (70,000,000)
Purchases of property and equipment, net (14,242,000) (51,263,000)
Increase in intangible assets (2,977,000) (4,322,000)
Business combinations, net of cash acquired 0 78,310,000
Other strategic investing activities 0 (6,750,000)
Net cash used in investing activities (17,219,000) (70,645,000)
Cash flows from financing activities:    
Proceeds from issuance of common stock 9,137,000 34,629,000
Payroll tax withholdings on behalf of employees for vested equity awards (16,724,000) (1,424,000)
Repurchases of common stock (128,917,000) (591,000)
Net cash (used in) provided by financing activities (136,504,000) 32,614,000
Effect of foreign currency exchange rates on cash 804,000 (847,000)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (67,661,000) 67,182,000
Cash, cash equivalents and restricted cash at end of period 575,955,000 631,881,000
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $ 577,343,000 $ 635,257,000